Reducing Opioid Use for Chronic Pain Patients Following Surgery
(RECOUP Trial)

Recruiting in Palo Alto (17 mi)

Overseen byDuminda Wijeysundera, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: University Health Network, Toronto

No Placebo Group

Trial Summary

What is the purpose of this trial?

This trial tests a program that helps surgery patients who use opioids manage their pain and reduce opioid use. The program includes education, therapy, and a mobile app. It aims to help patients understand and handle their pain better without needing opioids.

Eligibility Criteria

This trial is for adults over 18 who have been using opioids for chronic pain at doses of 20-200 mg oral morphine equivalents daily for at least a month before surgery. Participants must understand English, not be in palliative care or organ transplantation, and not use Methadone/Buprenorphine.

Inclusion Criteria

I am taking 20 to 200 mg of morphine or its equivalent daily before surgery.

Must have a personal email address for the set-up of the Manage My Pain (MMP) App or online multimedia tool

Able to read and understand English as posed on the questionnaire surveys prior to informed consent

See 3 more

Exclusion Criteria

I am not receiving palliative care, organ transplantation, or taking Methadone/Buprenorphine.

Treatment Details

Interventions

Transitional Pain Service Program (TPSP) (Behavioural Intervention)

Trial OverviewThe study tests the Transitional Pain Service Program (TPSP) which includes pain education, Acceptance and Commitment Therapy (ACT), and an e-mobile tool to manage chronic pain post-surgery. The goal is to reduce opioid dependency while managing pain effectively.

Participant Groups

2Treatment groups

Experimental Treatment

Active Control

Group I: Interventional GroupExperimental Treatment1 Intervention

Patients in the interventional group will be given a Transitional Pain Service follow-up appointment at the following postoperative time points (2 to 6 visits for the first two months, and then 1 to 2 visits on a monthly basis until one year). At each visit, patients will meet with the clinical psychologist and chronic pain specialist. Patients in the intervention group will have access to the Manage My Pain (MMP) App. which allows people living with pain to quickly and easily track their pain and function on a daily basis on their smartphones or a browser on their desktop or mobile device. One-page clinical reports will capture the changes in patients' outcome data between clinical visits over the course in time.Clinic visits can be offered in person at the hospital or over telehealth (video conference) based on the patient's preference and clinician's judgment for telehealth suitability.

Group II: Control GroupActive Control1 Intervention

Patients in the control group will receive standard care, which involves standard postoperative follow-up with their surgeon/primary care provider. Patients will also be sent with a link for an online multimedia tool during each follow-up time point that will provide information and education regarding non-pharmacologic techniques for managing pain. At the end, all patients in the control arm will be invited to join the TPSP after one year of follow-up if they are still taking opioids.